15934989

Source:http://linkedlifedata.com/resource/pubmed/id/15934989

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020687, umls-concept:C0032729, umls-concept:C0039421, umls-concept:C0205245, umls-concept:C1152182, umls-concept:C1280500, umls-concept:C1547011, umls-concept:C1879746, umls-concept:C2362067
pubmed:issue	6
pubmed:dateCreated	2005-6-6
pubmed:abstractText	Several strategies are being developed to reduce the risk of pathogen transmission associated with platelet (PLT) transfusion.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0417360
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Annexin A5, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins, http://linkedlifedata.com/resource/pubmed/chemical/Lysosome-Associated Membrane..., http://linkedlifedata.com/resource/pubmed/chemical/P-Selectin, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Glycoprotein GPIIb-IIIa..., http://linkedlifedata.com/resource/pubmed/chemical/Platelet Glycoprotein GPIb-IX..., http://linkedlifedata.com/resource/pubmed/chemical/Platelet Membrane Glycoprotein IIb, http://linkedlifedata.com/resource/pubmed/chemical/Riboflavin, http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0041-1132
pubmed:author	pubmed-author:EscolarGG, pubmed-author:FusteBB, pubmed-author:GalanA MAM, pubmed-author:GoodrichRR, pubmed-author:Lopez-VilchezII, pubmed-author:LozanoMM, pubmed-author:OOIS KSK, pubmed-author:Perez-PujolSS, pubmed-author:TondaRR
pubmed:issnType	Print
pubmed:volume	45
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	911-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15934989-Annexin A5, pubmed-meshheading:15934989-Antigens, CD, pubmed-meshheading:15934989-Blood Platelets, pubmed-meshheading:15934989-Blood Preservation, pubmed-meshheading:15934989-Fibrinogen, pubmed-meshheading:15934989-Fibronectins, pubmed-meshheading:15934989-Flow Cytometry, pubmed-meshheading:15934989-Humans, pubmed-meshheading:15934989-Lysosome-Associated Membrane Glycoproteins, pubmed-meshheading:15934989-P-Selectin, pubmed-meshheading:15934989-Platelet Activation, pubmed-meshheading:15934989-Platelet Adhesiveness, pubmed-meshheading:15934989-Platelet Count, pubmed-meshheading:15934989-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:15934989-Platelet Glycoprotein GPIb-IX Complex, pubmed-meshheading:15934989-Platelet Membrane Glycoprotein IIb, pubmed-meshheading:15934989-Platelet Transfusion, pubmed-meshheading:15934989-Plateletpheresis, pubmed-meshheading:15934989-Riboflavin, pubmed-meshheading:15934989-Temperature, pubmed-meshheading:15934989-Time Factors, pubmed-meshheading:15934989-Ultraviolet Rays, pubmed-meshheading:15934989-von Willebrand Factor
pubmed:year	2005
pubmed:articleTitle	Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
pubmed:affiliation	Hemotherapy-Hemostasis Service, CDB, Hospital Clinic, IDIBAPS, University of Barcelona, Spain.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies